OvaScience
IPO
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2011
- Business Model
- B2C
- Website
- ovascience.com
- Total Funding
- $150.8M
- Last Round
- $50.0M Corporate RoundDec 2018
About
OvaScience was a publicly traded biotechnology company focused on female infertility, applying novel science around egg precursor cells (EggPCSM cells) to improve egg quality and IVF outcomes. Founded in 2011 and based in Cambridge and later Waltham, Massachusetts, the company completed a reverse merger with Millendo Therapeutics in December 2018, ceasing to operate as OvaScience. The domain now redirects to an unrelated site.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free Account